Curcumin-Loaded Solid Lipid Nanoparticles Enhanced Anticancer Efficiency in Breast Cancer.

Area of Science:

• Nanotechnology
• Pharmacology
• Oncology

Background:

• Curcumin (Cur) possesses significant medicinal properties including antibacterial, anti-inflammatory, antioxidant, and antitumor effects.
• Clinical application of curcumin is hindered by its poor solubility and instability.
• Solid lipid nanoparticles (SLNs) offer a potential delivery system to overcome these limitations.

Purpose of the Study:

• To encapsulate curcumin into solid lipid nanoparticles (SLNs) to enhance its therapeutic efficacy for breast cancer.
• To characterize the curcumin-loaded SLNs (Cur-SLNs).
• To evaluate the in vitro anticancer activity of Cur-SLNs against breast cancer cells.

Main Methods:

• Curcumin was loaded into SLNs.
• Transmission electron microscopy (TEM) was used for morphological characterization.
• Drug loading and encapsulation efficiency were determined.
• Cytotoxicity, cellular uptake, and apoptosis induction were assessed in SKBR3 cells.
• Western blot analysis was performed to investigate molecular mechanisms.

Main Results:

• Cur-SLNs exhibited a spherical shape with a size of approximately 40 nm and a negative surface charge.
• Drug loading and encapsulation efficiency were 23.38% and 72.47%, respectively.
• Cur-SLNs demonstrated enhanced cytotoxicity, higher cellular uptake, and induced greater apoptosis in SKBR3 cells compared to free curcumin.
• Western blot analysis showed Cur-SLNs promoted the Bax/Bcl-2 ratio and decreased cyclin D1 and CDK4 expression.

Conclusions:

• Cur-SLNs represent a promising formulation for improving curcumin's therapeutic potential in breast cancer treatment.
• The enhanced efficacy is attributed to improved physicochemical properties and targeted cellular effects.
• Further investigation is warranted for clinical translation of Cur-SLNs in breast cancer therapy.